Abstract
Crohns disease and ulcerative colitis are characterized by periods of symptomatic relapse and remission. Diagnosis and assessment of inflammatory bowel disease has so far been based on clinical evaluation, serum parameters, radiology and endoscopy. Faecal markers such as calprotectin or lactoferrin have emerged as new diagnostic tools to detect and monitor intestinal inflammation. This review focuses on their potential clinical applications and limitations in the management of inflammatory bowel disease. © 2014, Sage Publications. All rights reserved.
Author supplied keywords
Cite
CITATION STYLE
Lehmann, F. S., Burri, E., & Beglinger, C. (2015). The role and utility of faecal markers in inflammatory bowel disease. Therapeutic Advances in Gastroenterology. https://doi.org/10.1177/1756283X14553384
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.